Website Launch Banner

All New VasoGuard Systems Introduced at SDMS Annual Conference

New PAD Diagnostic Suite Designed for Vascular Sonographers at the 2024 Society of Diagnostic Medical Ultrasound Conference in New Orleans

September 26, 20243 min read

New PAD Diagnostic Suite Designed for Vascular Sonographers

New Orleans -- September 26, 2024 -- CorVascular, a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) testing devices, began offering live demonstrations of its recently FDA-cleared VasoGuard V-Series medical devices. The company selected the 2024 Society of Diagnostic Medical Ultrasound (SDMS) annual conference to showcase the new products.

CorVascular received FDA clearance in July and immediately began production in order to deliver devices to clinics, hospitals, and teaching institutions across the country. "We are very excited to show the industry our new entrants into what has been a fairly stagnant response from the competition to the needs of vascular techs over the last decade. The SDMS Annual Conference is a great event and we look forward to showcasing our new products," said Spencer Lien, Founder and Managing Director at CorVascular.

CorVascular VasoGuard V-Series at SDMS 2024 Annual Conference

Five New VasoGuard Models with Advanced Features

There are five new VasoGuard models being introduced and each include features not seen among legacy offerings, including IP67 rated waterproof PPG sensors, independent pressure channels each equipped with an air flow sensor for Calibrated Pulse Volume Recording (C-PVR), and a built-in USB hub. The VasoGuard product platform ranges from the V2 (two independent pumps and two PPGs) up to the V10 with 10 independent pumps, three Doppler ports, and five PPGs.

These are just a few of the many features that makes the VasoGuard models a significant leap forward for physiologic testing. The advanced technology addresses the evolving needs of vascular sonographers and healthcare professionals who require reliable, accurate diagnostic tools for peripheral arterial disease assessment.

About CorVascular

CorVascular develops, manufactures, and markets innovative vascular testing technologies and is committed to its core strength in delivering accurate and reliable solutions to healthcare providers. Proudly headquartered and producing its products in the USA in the great state of Minnesota, CorVascular is privately held, eco-conscious, and an equal opportunity employer.

Follow CorVascular on X, Facebook, LinkedIn, and all other platforms to stay updated on the latest developments in vascular testing technology and upcoming product demonstrations.

Learn More About VasoGuard V-Series

Discover the advanced features and capabilities of our FDA-cleared VasoGuard V-Series devices designed for vascular sonographers.

VasoGuard V-Series Device

Receive Updates

Subscribe to our newsletter to receive the latest news and updates.